Thromb Haemost 1990; 64(02): 206-210
DOI: 10.1055/s-0038-1647286
Original Article
Schattauer GmbH Stuttgart

Hereditary Protein S Deficiency in Young Adults with Arterial Occlusive Disease

C F Allaart
1   The Haemostasis and Thrombosis Research Unit, University Hospital Leiden, The Netherlands
,
D C Aronson
2   The Dept. of Surgery, University Hospital Leiden, The Netherlands
,
Th Ruys
2   The Dept. of Surgery, University Hospital Leiden, The Netherlands
,
F R Rosendaal
3   The Dept. of Clinical Epidemiology, University Hospital Leiden, The Netherlands
,
J H van Bockel
2   The Dept. of Surgery, University Hospital Leiden, The Netherlands
,
R M Bertina
1   The Haemostasis and Thrombosis Research Unit, University Hospital Leiden, The Netherlands
,
E Briët
1   The Haemostasis and Thrombosis Research Unit, University Hospital Leiden, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 29 August 1989

Accepted after revision 08 August 1990

Publication Date:
25 July 2018 (online)

Summary

Protein S is the vitamin K dependent cofactor of activated protein C. It has an important role in the regulation of blood coagulation and fibrinolysis. Hereditary protein S deficiency is associated with familial venous thrombophilia. Since a few patients with arterial occlusions have been reported to be protein S deficient, it is speculated that hereditary protein S deficiency may be also a risk factor for the development of arterial thrombosis. In a group of 37 consecutive patients with arterial occlusive disease presenting before the age of 45, three patients were found heterozygous for hereditary protein S deficiency. None of the patients had a protein C deficiency or an antithrombin III deficiency. Family investigations showed a clear association between the hereditary deficiency and venous thrombosis, but a relation between the deficiency and arterial thrombosis was less obvious. A review of previous literature on patients with arterial thrombosis and protein S deficiency revealed that more extensive studies are needed to demonstrate whether or not hereditary protein S deficiency is a risk factor for the development of arterial thrombosis.

 
  • References

  • 1 DiScipio RG, Hermodson MA, Yates SG, Davie EW. A comparison of human prothrombin, factor IX, factor X and protein S. Biochemistry 1977; 16: 698-706
  • 2 Walker FJ. Regulation of activated protein C by a new protein. J Biol Chem 1980; 225: 5521-5524
  • 3 Walker FJ. Protein S and the regulation of activated protein C. Semin Thromb Haemostas 1984; 10: 131-138
  • 4 Abra RM, de Fouw NJ, Haverkate F, Bertina RM, Koopman J, van Wijngaar-den A, van Hinsbergh VW M. The cofactor role of protein S in the acceleration of whole blood clot lysis by activated protein C in vitro. Blood 1986; 67: 1189-1192
  • 5 Griffin JH, Evatt B, Zimmermann TS, Kleiss AJ, Wideman D. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981; 68: 1370-1373
  • 6 Bertina RM, Broekmans AW, vd Linden IK, Mertens K. Protein C deficiency in a Dutch family with thrombotic disease. Thromb Haemostas 1982; 48: 1-5
  • 7 Broekmans AW, Veltkamp JJ, Bertina RM. Congenital protein C deficiency and venous thrombo-embolism. A study in three Dutch families. N Engl J Med 1983; 309: 340-344
  • 8 Comp PC, Nixon RR, Cooper MR, Esmon CT. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 1984; 74: 2082-2088
  • 9 Schwarz HP, Fischer M, Hopmeier P, Batard MA, Griffin JH. Plasma protein S deficiency in familial thrombotic disease. Blood 1984; 64: 1297-1300
  • 10 Engesser L, Broekmans AW, Briet E, Brommer EJ P, Bertina RM. Hereditary protein S deficiency: clinical manifestations. Ann Intern Med 1987; 106: 677-682
  • 11 Coller BS, Owen J, Jesty J, Horowitz D, Reitman MJ, Spear J, Yeh T, Comp PC. Deficiency of plasma protein S, protein C or antithrombin III and arterial thrombosis. Arteriosclerosis 1987; 7 (05) 456-462
  • 12 Mannucci PM, Tripodi A, Bertina RM. Protein S deficiency associated with “juvenile” arterial and venous thrombosis. Thromb Haemostas 1986; 55: 440
  • 13 Israels SJ, Seshia SS. Childhood stroke associated with protein C or S deficiency. J Pediatr 1987; 111: 562-564
  • 14 Girolami A, Simioni P, Lazzaro AR, Cordiano I. Severe arterial cerebral thrombosis in a patient with protein S deficiency (moderately reduced total and markedly reduced free protein S): a family study. Thromb Haemostas 1989; 61: 144-147
  • 15 von Felten A, Hoechli P, Gerber J, Raeber D, Schoch U. Zerebral-thrombosen bei jungen Patienten mit Protein-S-Mangel: Hinweis auf ein erhohtes arterielles Thromboserisiko?. Schweiz Med Wschr 1988; 118 (Suppl. 02) 59 (abstr)
  • 16 Thommen D, Buhrfeind E, Felix R, Sulzer I, Furlan M, Lammle B. Hamostaseparameter bei 55 Patienten mit venosen und/oder arteriel-len Thromboembolien. Schweiz Med Wschr 1989; 119 (16) 493-499
  • 17 Schafer HP, von Felten A. Protein-S-Mangel bei jungen Patienten mit thrombotischen Himinfarkten. Schweiz Med Wschr 1989; 119: 489-492
  • 18 Sie P, Boneu B, Bierme R, Wiesel ML, Grunebaum L, Cazenave JP. Arterial thrombosis and protein S deficiency. Thromb Haemostas 1989; 62 (03) 1040
  • 19 Aronson DC, Ruys T, Bockel JH, Briet E, Brommer EJ P, Gevers LeuvenJ A, Kempen HJ M, Feuth JD M, Giesberts MA H. A prospective survey of risk factors in young adults with arterial occlusive disease. Eur J Vase Surg 1989; 3: 227-232
  • 20 Deutz-Terlouw PP, Ballering L, van Wijngaarden A, Bertina RM. Two ELISA’s for measurement of protein S and their use in the laboratory diagnosis of protein S deficiency. Clin Chom A (in press)
  • 21 Bertina RM, van Wijngaarden A, Reinalda-Poot J, Poort SR, Bom VJ J. Determination of plasma protein S - The protein cofactor of activated protein C. Thromb Haemostas 1985; 53: 268-272
  • 22 Koedam JA, Meyers JC M, Sixma JJ, Bouma BN. Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor. J Clin Invest 1988; 82: 1236-1243
  • 23 Gardiner JE, McGann MA, Berridge CW, Fulcher CA, Zimmerman TS, Griffin JH. Protein S as a cofactor for activated protein C in plasma and in the inactivation of purified factor VIII: C. Circulation 1984; 70 02: 205 (abstr)
  • 24 Comp PC, Esmon CT. Generation of fibrinolytic activity by infusion of activated protein C into dogs. J Clin Invest 1981; 68: 1221-1228
  • 25 Dahlback B. Inhibition of the protein C cofactor function of human and bovine protein S by C4b-binding protein. J Biol Chem 1986; 261: 12022-12027
  • 26 Marlar RA. Protein C in thromboembolic disease. Sem Thromb Haemostas 1985; 11: 387-393
  • 27 Bovill EG, Bauer KA, Dickerman JC, Callas P, West hB. The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. Blood 1989; 73 (03) 712-717
  • 28 Gladson CL, Scharrer I, Hack V, Beck KH, Griffin JH. The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis. Thromb Haemostas 1988; 59: 18-22
  • 29 Engesser L, Briet E, Dubbeldam J, Kret MJ, Brommer EJ P. Disorders of coagulation and fibrinolysis and their association with venous thrombophilia. Thesis, Leiden 1988; 91: 127
  • 30 Ben-Tal O, Zivelin A, Seligsohn U. The relative frequency of hereditary thrombotic disorders among 107 patients with thrombophilia in Israel. Thromb Haemostas 1989; 61: 50-54
  • 31 Chancellor AM, Glasgow GL, Ockelford PA, Johns A, Smith J. Etiology, prognosis, and hemostatic function after cerebral infarction in young adults. Stroke 1989; 20: 477-482
  • 32 Griffin JH, Heeb MJ, Schwarz HP. Plasma protein S deficiency and thromboembolic disease. Progr Hematol 1987; XV: 39-49